Mustafa Özkaraca

12PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsWaste management, reduction, reuse and recyclingMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 17, 2026
Dapagliflozin ameliorates motor deficits in a Parkinson's disease model induced by 6-OHDA: An integrative in vivo and in silico approach from α-synuclein/A2AAR/TH/TNF-α to APAF-1/caspase-3 modulation.

|Mar 06, 2026
Correction: Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities.

Gözde Atila Uslu, Hamit Uslu, Taha Abdulkadir Çoban

|Jul 29, 2025
Sunitinib treatment reduces proinflammatory cytokine levels and mortality rates by suppressing the NLRP3 inflammasome signaling pathway in sepsis.

Ahmet Kucuk, Nurhak Aksungur, Zekai Halici

|Jul 14, 2025
Effects of apigenin, hesperidin and their combinations on different physiopathological pathways in 5-fluorouracil-induced pulmonary damage.

Hamit Uslu, Gözde Atila Uslu, Taha Abdulkadir Çoban

|May 30, 2025
Hepatoprotective Activity of Prunus laurocerasus Fruit Extract Against 5-FU-Induced Liver Injury and LC-MS/MS Profiling.

Gözde Atila Uslu, Hamit Uslu, Taha Abdulkadir Çoban

|May 13, 2025
Protective Effect of HMG-CoA Reductase Inhibitor Rosuvastatin on Doxorubicin-Induced Cognitive Impairment, Oxidative Stress and Neuroinflammation: Possible Role of CREB, ERK1/2, and BDNF.

Yesim Yeni, Betul Cicek, Ahmet Hacimuftuoglu

Pageof 2

Frequent Collaborators

4 joint publications

Hamit Uslu

4 joint publications

Gözde Atila Uslu

4 joint publications

Taha Abdulkadir Çoban

4 joint publications

Ali Sefa Mendil